 |
Ketoconazole |
|---|---|
| Trade Name | Nizoral |
| Orphan Indication | For use with cyclosporine A to diminish the nephrotoxicity induced by cyclosporine in organ transplantation |
| USA Market Approval | USA |
| USA Designation Date | 1991-03-27 00:00:00 |
| Sponsor | Pharmedic Company;28101 Ballard Road;Lake Forest, Illinois, 60045 |
